Making antigen presentable.
作者信息
Allen Paul M
机构信息
Department of Pathology and Immunology, Washington University School of Medicine, 660 South Euclid, St. Louis, MO 63110, USA.
出版信息
J Immunol. 2007 Jul 1;179(1):3-4. doi: 10.4049/jimmunol.179.1.3.
PMID:17579012
Abstract
摘要
相似文献
1
Making antigen presentable.
J Immunol. 2007 Jul 1;179(1):3-4. doi: 10.4049/jimmunol.179.1.3.
2
From antigen processing to peptide-MHC binding.
Nat Immunol. 2006 Dec;7(12):1277-9. doi: 10.1038/ni1206-1277.
3
Immunology. Making class II presentable.
Nature. 1994 May 12;369(6476):103-4. doi: 10.1038/369103a0.
4
The Medawar Prize acceptance speech 2014.
Transplantation. 2015 Feb;99(2):254-7. doi: 10.1097/TP.0000000000000627.
5
Introduction of David H. Sachs, MD, recipient of the 2014 Medawar Prize.
Transplantation. 2015 Feb;99(2):253-4. doi: 10.1097/TP.0000000000000594.
6
[MHC class II restricted antigen presentation].
Nihon Rinsho. 2005 Apr;63 Suppl 4:299-303.
7
The first structures of T cell receptors bound to peptide-MHC.
J Immunol. 2010 Dec 1;185(11):6391-3. doi: 10.4049/jimmunol.1090110.
8
Antigen presentation to naive CD4 T cells in the lymph node.
Nat Immunol. 2003 Aug;4(8):733-9. doi: 10.1038/ni957.
9
A gene in the human major histocompatibility complex class II region controlling the class I antigen presentation pathway. 1990.
J Immunol. 2008 Mar 1;180(5):2737-40.
10
CpG DNA switches on Th1 immunity and modulates antigen-presenting cell function.
Curr Top Microbiol Immunol. 2000;247:199-210. doi: 10.1007/978-3-642-59672-8_14.
引用本文的文献
1
Development of multi-epitope vaccines targeting wild-type sequence p53 peptides.
Expert Rev Vaccines. 2008 Sep;7(7):1031-40. doi: 10.1586/14760584.7.7.1031.
Zotero 插件